Register for Newsletter

Startup

Hyderabad based CSIR institutes playing pivotal role in drug discovery and genetic diagnostics: Dr. Jitendra Singh
Hyderabad based CSIR institutes playing pivotal role in drug discovery and genetic diagnostics: Dr. Jitendra Singh
Mila Beaute raises $2.16 million in pre-series A round led by Rukam Capital
Mila Beaute raises $2.16 million in pre-series A round led by Rukam Capital
Merck Life Science India signs MoU with DPIIT
Merck Life Science India signs MoU with DPIIT
View More

Digitization

Wanbury to implement the SAP S/4 HANA private cloud platform
Wanbury to implement the SAP S/4 HANA private cloud platform
Rockwell Automation empowers NKP Pharma achieve regulatory compliance
Rockwell Automation empowers NKP Pharma achieve regulatory compliance
Honeywell launches AI-assisted automation platform for life sciences manufacturing industry
Honeywell launches AI-assisted automation platform for life sciences manufacturing industry
View More

Latest Stories

Medanta to set up a 400-bed super specialty hospital in Guwahati

ekincare raises investment from MSD IDEA Studio Asia Pacific

Indegene posts Q4 FY25 consolidated PAT at Rs. 117.6 Cr

Vimta Labs to invest Rs. 50 crores to Biologics CDMO business foray

IOL Chemicals and Pharmaceuticals receives approval CDE of NMPA, China for Ibuprofen

Opinion
Injection filter needle market to reach $1.73 billion in 2025
Injection filter needle market to reach $1.73 billion in 2025
Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals
Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals

Interviews
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging